NORTH AMERICAN BIOLOGICALS INC  NBIO 4TH QTR MIAMI MARCH 3 OPER SHR ONE CT VS THREE CTS OPER NET 99000 VS 327000 REVS 121 MLN VS 8800000 AVG SHRS 155 MLN VS 113 MLN YEAR OPER SHR SIX CTS VS 11 CTS OPER NET 841000 VS 956000 REVS 441 MLN VS 344 MLN AVG SHRS 153 MLN VS 8519677 NOTE NET EXCLUDES TAX CREDITS OF 299000 DLRS VS 2900000 DLRS IN QUARTER AND 809000 DLRS VS 71000 DLRS IN YEAR   